Clinical Trial Update: Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated tipifarnib in patients with chronic myelomonocytic leukemia and other myelodysplastic/myeloproliferative neoplasms and acute myeloi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Myeloproliferative Neoplasm
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• Tipifarnib (tipifarnib)

Snippet

Sponsor: Kura Oncology, Inc. | Conditions: Leukemia, Myelomonocytic, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2024-07-17